Hagar Lands Funding To Develop Noninvasive Glucose Monitoring Watch
Hagar is planning to put its GWave non-invasive continuous glucose monitoring (CGM) technology in a smartwatch and eventually sell the technology to a larger medtech player that can market it globally.
Diabetes startup brews up $11M after 'serendipitous spill' led to creation of new CGM tech
Many of the most groundbreaking discoveries have happened accidentally: The microwave oven, for one, was developed after physicist Percy Spencer noticed a chocolate bar in his pocket had melted while he was experimenting with a magnetron.
Hagar Brings in $11.7M for CGM Conceptualized from Tea Spill
The financing follows $4.4 million the Tel Aviv, Israel-based company raised earlier this year.
Hagar has raised $11.7 million in a series B round to push forward GWave, a non-invasive continuous glucose monitoring technology, that originated from a spilled cup of tea.
HAGAR Secures $11.7M Series B Funding to Advance Non-Invasive Blood Glucose Monitoring Technology
HAGAR, the developer of GWave, the world’s first non-invasive continuous glucose monitoring technology that uses RF waves to measure glucose levels in the blood, announced an $11.7 million Series B funding round led by a returning investor, Columbia Pacific.
Diabetes startups brew $ 11M after “accidental spills” lead to the creation of new CGM technology
Many of the most groundbreaking discoveries happened by accident. For example, the microwave oven was developed after physicist Percy Spencer noticed that the chocolate bar in his pocket had melted during a magnetron experiment.